scispace - formally typeset
K

Kyoko Komai

Researcher at Keio University

Publications -  14
Citations -  1180

Kyoko Komai is an academic researcher from Keio University. The author has contributed to research in topics: T cell & Immune tolerance. The author has an hindex of 10, co-authored 13 publications receiving 796 citations. Previous affiliations of Kyoko Komai include Japan Agency for Medical Research and Development.

Papers
More filters
Journal ArticleDOI

Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery

TL;DR: It is shown that there is massive accumulation of Treg cells in the mouse brain after ischaemic stroke, and this potentiates neurological recovery during the chronic phase of ischaemia brain injury.
Journal ArticleDOI

The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential.

TL;DR: It is found that diabetic db/db mice which lack the leptin receptor signaling can be used as a model of ESRD associated with DN and systemic administration of rapamycin markedly ameliorated pathological changes and renal dysfunctions, indicating that mTOR activation plays a pivotal role in the development of E SRD.
Journal ArticleDOI

MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1

TL;DR: It is demonstrated that common DAMPs, such as high-mobility-group box 1 (HMGB1), peroxiredoxins, and S100A8 and S 100A9, were internalized through the class A scavenger receptors MSR1 and MARCO in vitro, and cellular mechanisms contributing to DAMP clearance in resolution of the sterile inflammation triggered by tissue injury are uncovered.
Journal ArticleDOI

Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance

TL;DR: It is proposed that SOCS1 and PGE2, potentially interacting together, act as an alternative intestinal tolerance mechanism distinct from IL-10 and Tregs, as an essential mediator of immune tolerance in the intestine.